Navigation Links
Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT)
Date:7/10/2014

t patients or discharge them on outpatient therapy.
  • Preference for oral antibiotics over OPAT: Oral therapies offer the potential to substantially simplify antibiotic treatment compared with therapies that are administered intravenously. Not surprisingly, surveyed ID specialists reported being more likely to prescribe oral formulations of both Cubist's Sivextro (tedizolid) and Tetraphase's emerging drug eravacycline when discharging patients than OPAT with either drug, suggesting oral formulations of these agents will see greater use as discharge therapy.
  • Comments from Decision Resources Group Analyst Hannah E. Cummings, Ph.D.:

    • "Hospitals are actively looking to cut costs and reduce or shorten admissions, and discharging patients on OPAT is an important part of their strategy. OPAT is a particularly attractive treatment modality for patients presenting to the emergency room with an infection requiring IV antibiotic therapy but not necessitating admission. ID specialists and emergency room physicians are frequently involved in identifying and recommending patients for OPAT and will likely be key stakeholders in driving uptake of new OPAT therapies."
    • "Surveyed ID specialists identified a need for new OPAT drugs for infections due to drug-resistant pathogens that are dosed once daily. Although the OPAT market is highly genericized, agents demonstrating benefits in efficacy, dosing-frequency and/or administration, such as Cubist's Cubicin (daptomycin) and Merck's Invanz (ertapenem), have experienced widespread use in the OPAT market. New agents will also have to demonstrate improvements on these key attributes to successfully compete in the OPAT market segment."

    About Decision Resources Group
    Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare indu
    '/>"/>

    SOURCE Decision Resources Group
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. Janssen R&D Ireland Announces Agreement with PATH for Early Development of Rilpivirine in Long-Acting Formulation for Potential Prophylactic Intervention
    2. Beyond the Headlines: What the FDA Decisions on Extended-release and Long-Acting Opioids Mean for People With Pain
    3. WomanCare Global launches Simplant, Long-acting Reversible Contraception, in Chile
    4. PROLOR Biotech To Present Preclinical Data On Its Long-Acting Clotting Factor Vlla At 2012 ASH Annual Meeting
    5. Study Published In Contraception Evaluates Medical Expenditures For Unintended Pregnancies And Potential Cost Impact Of Increased Use Of Long-Acting Reversible Contraception
    6. Purdue Pharma L.P. Comments on FDA Announcement on REMS for Extended-Release and Long-Acting Opioid Analgesics
    7. Applegate CEO Worries FDA Plan To Address Antibiotics In Animal Agriculture Is Too Little, Too Late
    8. AVMA lauds FDA for new regulation of antibiotics in livestock feed
    9. Debiopharm Group and TCG Lifesciences Ltd. Enter into an Exclusive Research Agreement to Develop a Novel Class of Antibiotics, a New Strategic Therapeutic Area for Debiopharm
    10. Rising Drug Resistance is Driving Early-Line Use of Powerful Antibiotics Such as Carbapenems for Gram-Negative Infections, According to Surveyed EU5 Physicians
    11. Antibiotic Resistance 2013: The Antibiotics Development Pipeline and Strategies to Combat Antibiotic Resistance
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/29/2015)... DIEGO and WALTHAM, Mass., July 29, 2015 ... is investigating whether certain officers and ... their fiduciary duties to shareholders.  AMAG Pharmaceuticals operates ... maternal health, anemia, and cancer supportive care.  The ... reduce the risk of preterm birth in women ...
    (Date:7/29/2015)... Heska Corporation (NASDAQ: HSKA - News; ... diagnostic and other specialty veterinary products , today reported financial ... Second Quarter 2015 Highlights with Prior Year Comparison: ... $1.829 million, from $917 thousand. , Blood Analyzer and ... , Core Companion Animal revenue was up 19% to ...
    (Date:7/29/2015)... 2015 The Judicial Panel on Multidistrict Litigation ... to centralize Inferior vena cava (IVC) Filter lawsuits filed ... Medical, have already been centralized by the JPML. ... at risk for a pulmonary embolism. The filters are ... lungs. Claims against Bard and Cook involve incidents of ...
    Breaking Medicine Technology:Robbins Arroyo LLP Is Investigating the Officers and Directors of AMAG Pharmaceuticals, Inc. (AMAG) on Behalf of Shareholders 2Heska Reports Financial Results for the Second Quarter of 2015 2Heska Reports Financial Results for the Second Quarter of 2015 3Heska Reports Financial Results for the Second Quarter of 2015 4Heska Reports Financial Results for the Second Quarter of 2015 5Heska Reports Financial Results for the Second Quarter of 2015 6Heska Reports Financial Results for the Second Quarter of 2015 7Heska Reports Financial Results for the Second Quarter of 2015 8IVC filter litigation continues; law firm provides free information to IVC filter patients 2
    (Date:7/29/2015)... , ... July 29, 2015 , ... Avatar Solutions has ... Systems (CAHPS) for PQRS Survey. , The CAHPS for PQRS Survey collects ... of 100 or more eligible providers must participate or they will receive a 2% ...
    (Date:7/29/2015)... ... July 29, 2015 , ... In an ... with the problems of substance abuse that face today’s society, A Forever Recovery ... come to their rehabilitation center. The facility, located in Southwest Michigan hosted a ...
    (Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... Conventional theories ... and trade goods and services may be able to unlock mysteries about the behavior ... Graduate University , Boston University, and Columbia University. , The findings, published July 29 ...
    (Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... production, announced today that Columbia University Medical Center, located in New York, NY, ... studio makes it easy for physicians and scientists to immediately access worldwide TV ...
    (Date:7/29/2015)... ... July 29, 2015 , ... Abt ... within Abt’s U.S. Health division. In her position, Ramkeesoon will help build ... to joining Abt, Ramkeesoon spent close to a decade at ICF International, most ...
    Breaking Medicine News(10 mins):Health News:Avatar Solutions Approved to Administer CAHPS for Physician Quality Reporting System (PQRS) 2Health News:Avatar Solutions Approved to Administer CAHPS for Physician Quality Reporting System (PQRS) 3Health News:MADD Victim Services Specialist Visits A Forever Recovery Rehabilitation Facility 2Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 2Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 3Health News:Columbia University Medical Center Installs a VideoLink ReadyCam® Video Studio on Campus; Medical Experts Able to Appear on Live TV at a Moment's Notice 2Health News:Columbia University Medical Center Installs a VideoLink ReadyCam® Video Studio on Campus; Medical Experts Able to Appear on Live TV at a Moment's Notice 3Health News:Selena Ramkeesoon Joins Abt Associates as Vice President for Strategic Communications 2
    ... largest meat processor, Maple Leaf Foods, on Tuesday decided to ... of its meat // products with an unknown contaminant. ... when Maple Leaf Employees found syringe casings at the company's ... Federal agency and CFIA's food safety officer, Garfield Balsom took ...
    ... World Ayurveda Congress at the University of Pune on ... Anbumani Ramadoss, //announced a series of steps to be ... India and abroad. He said, 'In a scenario where ... India’s rich tradition needed to be tapped and packaged ...
    ... wonder then, that the University of Queensland, Queensland ... David Fleay's Wildlife Park and the Zoological Society ... interesting project. The combined project is an artificial ... Monday and scientists believe the technique can be ...
    ... filed an appeal with the Pakistan Cricket Board (PCB) to ... tribunal on Nov 1.// ,Shoaib handed over the ... newspaper Wednesday quoted the PCB spokesperson as saying. ,Another ... ban by the same doping tribunal, filed his appeal to ...
    ... study that by actually allowing a stream of mild electrical ... stimulate a person’s mind helping him definitely to clearly recall ... ordinarily be able to do. ,Neuroscientist Lisa Marshall of ... found that applying electrical stimuli to the brain scalp which ...
    ... hearted - there is a 1 in 300 chance of dying ... England Sir Liam Donaldson has said in a cautionary message . ... WHO's campaign on the need for hospitals to address hygiene issues ... the chances of dying in an aircrash hollow , where the ...
    Cached Medicine News:Health News:Government Announces Steps To Promote Ayurvedic Medicine 2
    The base of the staple is round and threaded to enable screwing onto the stapler. The base also has spikes. The legs of the staple are contoured to prevent the staple from backing out....
    ... Cement consists of a two ... bone cement liquid within a ... polyethylene bag,containing bone cement powder ... interiors of the blister pack,and ...
    ... ORTHOSET Radiopaque Bone Cement ... system: a sterile,ampule containing bone ... pack, and a sterile polyethylene ... a peelable pouch. The interiors ...
    A "doughy" type of bone cement intended for manual application....
    Medicine Products: